miR-7-5p acts as a tumor suppressor in bladder cancer by regulating the hedgehog pathway factor Gli3

2018 ◽  
Vol 503 (3) ◽  
pp. 2101-2107 ◽  
Author(s):  
Jun Li ◽  
Mingxing Qiu ◽  
Yu An ◽  
Jianlin Huang ◽  
Chunyu Gong
2021 ◽  
Vol 30 ◽  
pp. 096368972098511
Author(s):  
Gang Li ◽  
Xu Zhang ◽  
Xiangyang Guo ◽  
Yi Li ◽  
Chong Li

Bladder cancer is one of the most common malignancies. The existence of bladder cancer stem cells (BCSCs) has been suggested to underlie bladder tumor initiation and recurrence. Propofol is a commonly used intravenous anesthetic. Here, we find that propofol can dramatically block the activation of Hedgehog pathway in BCSCs. The propofol strongly repressed the growth of cancer cells. Attenuated proliferation and enhanced apoptosis of tumor cells were observed upon propofol stimulation. Furthermore, propofol reduced the self-renewal ability of BCSCs as well as the tumor formation. In conclusion, propofol is potentially used as a novel therapeutic agent for bladder cancer by targeting self-renewal through inhibiting Hedgehog pathway.


Author(s):  
Hiroyuki Nishiyama ◽  
Takeshi Takahashi ◽  
Yoshiyuki Kakehi ◽  
Tomonori Habuchi ◽  
Margaret A. Knowles

2015 ◽  
Vol 3 ◽  
pp. 561-569 ◽  
Author(s):  
Gongbin Lan ◽  
Luoyan Yang ◽  
Xubiao Xie ◽  
Longkai Peng ◽  
Yi Wang

2007 ◽  
Vol 352 (2) ◽  
pp. 549-555 ◽  
Author(s):  
Mikael Herlevsen ◽  
Gary Oxford ◽  
Celeste Ptak ◽  
Jeffrey Shabanowitz ◽  
Donald F. Hunt ◽  
...  

2018 ◽  
Vol 199 (4S) ◽  
Author(s):  
Satoshi Sugita ◽  
Hirofumi Yoshino ◽  
Kazutaka Miyamoto ◽  
Masaya Yonemori ◽  
Takashi Sakaguchi ◽  
...  

Oncogene ◽  
1999 ◽  
Vol 18 (1) ◽  
pp. 157-163 ◽  
Author(s):  
Maryse Simoneau ◽  
Tahar O Aboulkassim ◽  
Hélène LaRue ◽  
François Rousseau ◽  
Yves Fradet

Sign in / Sign up

Export Citation Format

Share Document